D70.1Billable
Agranulocytosis secondary to cancer chemotherapy
Chapter 2: Neoplasms
Use Additional Code
1 item
Use Additional Code
- •code for adverse effect, if applicable, to identify drug (T45.1X5)
Billable Code
D70.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Referenced in Diagnoses
Conditions that use this ICD-10 code in their documentation
View documentation for chemotherapy induced neutropenia
chemotherapy induced neutropenia
View TemplatesAgranulocytosis secondary to cancer chemotherapy
View documentation for colony-stimulating factor
colony-stimulating factor
View TemplatesColony-Stimulating Factor Administration
View documentation for decreased white blood cells
decreased white blood cells
View TemplatesLeukopenia
View documentation for elevated neutrophils
elevated neutrophils
View TemplatesNeutrophilia
View documentation for febrile neutropenia
febrile neutropenia
View TemplatesFebrile Neutropenia
View documentation for increase neutrophil
increase neutrophil
View TemplatesNeutrophilia
View documentation for leukocytopenia
leukocytopenia
View TemplatesLeukocytopenia
View documentation for leukopenia
leukopenia
View TemplatesLeukopenia
View documentation for low white blood cells
low white blood cells
View TemplatesLeukopenia
View documentation for neutropenia
neutropenia
View TemplatesNeutropenia
View documentation for neutropenia due to chemotherapy
neutropenia due to chemotherapy
View TemplatesAgranulocytosis secondary to cancer chemotherapy
View documentation for neutropenic fever
neutropenic fever
View TemplatesNeutropenic Fever
View documentation for neutropenic sepsis
neutropenic sepsis
View TemplatesNeutropenic Sepsis
View documentation for neutrophils
neutrophils
View TemplatesNeutrophil Abnormalities
Additional Information from Parent Codes
The following information may apply to this code from its parent codes in the ICD-10 hierarchy. This information is important for proper coding and classification.
Parent Codes Referenced:
Includes
2 items
Includes
From D70:
- •agranulocytosis
- •decreased absolute neurophile count (ANC)
Notes
8 items
Notes
From C00-D49:
- •Functional activity
- •All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- •Morphology [Histology]
- •Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- •Primary malignant neoplasms overlapping site boundaries
- •A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- •Malignant neoplasm of ectopic tissue
- •Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).